WAVE Life Sciences Ltd (FRA:1U5)
€ 12.8 -0.1 (-0.78%) Market Cap: 1.89 Bil Enterprise Value: 1.62 Bil PE Ratio: 0 PB Ratio: 13.52 GF Score: 41/100

WAVE Life Sciences Ltd at RBC Capital Markets Global Healthcare Conference Transcript

May 17, 2022 / 06:05PM GMT
Release Date Price: €1.16 (+2.11%)
Luca Issi
RBC Capital Markets, LLC - Analyst

Luca Issi, senior biotech analyst here at RBC Capital Market. And today, it's our great privilege to have Wave Life Sciences with us for a fireside chat. Representing the company, we have Paul Bolno, Chief Executive Officer. Paul, thanks so much for joining us. How are you doing today?

Paul Bolno
Wave Life Sciences Ltd. - President & CEO

Well, thank you. It's so awesome that we are just saying for everybody else. It is great to be back in an in-person investor conference. So this is fun. This is our first in-person fireside chat, so this will be fun.

Questions & Answers

Luca Issi;Paul Bolno
RBC Capital Markets, LLC - Analyst;Wave Life Sciences

That's fantastic. Glad that RBC has that privilege. So we have a long list of questions, but maybe before we talk about individual programs, can you just talk about what progress the organization has made over the last few months and maybe most importantly, what's ahead here for Wave?

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot